Xerofast-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100 mg), Paracetamol (325 mg), and Serratiopeptidase (15 mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of swelling and edema, enhancing tissue repair. The synergistic action of these three components makes Xerofast-SP effective in managing musculoskeletal disorders, postoperative pain, dental pain, and inflammatory conditions such as arthritis and soft tissue injuries. This combination is particularly beneficial in reducing pain, inflammation, and associated discomfort, thereby improving patient mobility and quality of life. Xerofast-SP should be used under medical supervision, with caution advised in patients with gastrointestinal, renal, or hepatic impairments. It is contraindicated in individuals with known hypersensitivity to any component and should be avoided during pregnancy and lactation unless deemed necessary by a healthcare professional.